financetom
Business
financetom
/
Business
/
Lattice Semiconductor beats Q2 revenue estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lattice Semiconductor beats Q2 revenue estimates
Aug 4, 2025 1:19 PM

Overview

* Lattice Semiconductor ( LSCC ) fiscal Q2 rev beats analyst expectations, per LSEG data

* Adjusted EPS for fiscal Q2 meets analyst estimates, per LSEG data

* Co highlights broad-based growth and record design wins

Outlook

* Lattice expects Q3 2025 revenue between $128 mln and $138 mln

* Company anticipates Q3 2025 non-GAAP gross margin around 69.5%

* Lattice forecasts Q3 2025 net income per share between $0.26 and $0.30

* Company sees continued strength in communications and computing markets

Result Drivers

* BROAD-BASED GROWTH - Co attributes Q2 performance to broad-based growth across key financial metrics and record design wins

* MARKET RECOVERY - Industrial and automotive markets are recovering, with channel inventory levels improving

* AI ACCELERATORS - Future growth expected from major design wins alongside AI accelerators in Cloud datacenter, wired communications, industrial robotics, ADAS, and other far-edge AI applications

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $123.97 $123.60

Revenue mln mln (13

Analysts

)

Q2 Meet $0.24 $0.24

Adjusted (13

EPS Analysts

)

Q2 EPS $0.02

Q2 Net $2.91

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the semiconductors peer group is "buy"

* Wall Street's median 12-month price target for Lattice Semiconductor Corp ( LSCC ) is $63.00, about 22.2% above its August 1 closing price of $48.99

* The stock recently traded at 39 times the next 12-month earnings vs. a P/E of 40 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Factbox-Tesla shareholder meeting: How investors are voting on Musk's $56-billion pay package
Factbox-Tesla shareholder meeting: How investors are voting on Musk's $56-billion pay package
Jun 12, 2024
(Reuters) - Investors will vote on Tesla CEO Elon Musk's $56-billion compensation package and the company's reincorporation in Texas, from Delaware, at a consequential shareholder meeting this week. Analysts have flagged risk of the billionaire potentially leaving the electric-vehicle maker and prioritizing artificial intelligence startup xAI and social media platform X if the pay package does not pass. Here are...
Why Zillow Group Stock Is Trading Higher Wednesday
Why Zillow Group Stock Is Trading Higher Wednesday
Jun 12, 2024
Zillow Group, Inc. ( ZG ) shares are moving higher Wednesday after SEC filing shows director Jay Hoag bought 2,338,036 shares. What To Know: The filing from late Tuesday indicates the director bought approximately two million shares at an average price of $43.76 a share. The total value of the purchase is about $99.97 million, according to data from Benzinga...
US agency seeks answers from Waymo in self-driving vehicle probe
US agency seeks answers from Waymo in self-driving vehicle probe
Jun 12, 2024
WASHINGTON, June 12 (Reuters) - The National Highway Traffic Safety Administration said Wednesday it is seeking additional details about a series incidents that raise concerns about the performance of Alphabet's Waymo self-driving vehicles. In May, the U.S. auto safety regulator opened an investigation after 22 reports of its robotaxis exhibiting driving behavior that potentially violated traffic safety laws, or demonstrating...
Biogen executive plays down looming competition for its Alzheimer's drug
Biogen executive plays down looming competition for its Alzheimer's drug
Jun 12, 2024
June 12 (Reuters) - Biogen's Alzheimer's drug, Leqembi, will do well in the market whether a competitor comes or not, a company executive said at the Goldman Sachs Global Healthcare Conference on Wednesday. Leqembi, co-developed by Biogen and its Japanese partner Eisai ( ESALF ), had won standard approval from the U.S. Food and Drug Administration last July. It sees...
Copyright 2023-2026 - www.financetom.com All Rights Reserved